AYTU vs CAH · rev $66.4M vs P/E 35, rev $254.25B
Aytu BioScience Inc (AYTU) versus Cardinal Health Inc (CAH) — a side-by-side from cached financials, not a winner call.
Aytu BioScience Inc (AYTU) is a drug manufacturers - specialty & generic company listed on US.
Cardinal Health Inc (CAH) is a medical distribution company listed on NYSE.
Latest reported AYTU revenue for 2025-06-30 was $66.4M. Net income was -$13.6M. AYTU currently screens at market cap $24.1M.
Latest reported CAH revenue for 2026-06-30 was $254.25B. Net income was $1.71B. Revenue was up 14.2% from 2025-06-30 to 2026-06-30. CAH currently screens at market cap $53.00B and trailing P/E 34.6.
AYTU currently screens at market cap $24.1M. CAH currently screens at market cap $53.00B and trailing P/E 34.6.
Not investment advice. Open the AYTU and CAH stock pages for the full models.
Not investment advice.